Universal Ibogaine (TSXV:IBO) Pretax Margin %: -9.42% (As of Apr. 2025)


What is Universal Ibogaine Pretax Margin %?

Universal Ibogaine TSXV:IBO Pretax Margin % is -9.42% as of Apr. 2025.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Universal Ibogaine's Pre-Tax Income for the three months ended in Apr. 2025 was C$-0.07 Mil. Universal Ibogaine's Revenue for the three months ended in Apr. 2025 was C$0.70 Mil. Therefore, Universal Ibogaine's pretax margin for the quarter that ended in Apr. 2025 was -9.42%.

The historical rank and industry rank for Universal Ibogaine's Pretax Margin % or its related term are showing as below:


TSXV:IBO's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -89.42
* Ranked among companies with meaningful Pretax Margin % only.

Universal Ibogaine  (TSXV:IBO) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Universal Ibogaine Pretax Margin % Related Terms

Universal Ibogaine Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Universal Ibogaine's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universal Ibogaine Pretax Margin % Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23 Jul24
Pretax Margin %
Get a 7-Day Free Trial 0.00 0.00 -980.02 -232.04 -88.03

Universal Ibogaine Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -160.52 -135.78 -80.89 -81.72 -9.42

TSXV:IBO vs LABT, CALC, LNAI: Pretax Margin % Comparison

For the Biotechnology subindustry, Universal Ibogaine's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Universal Ibogaine Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's Pretax Margin % falls into.


Universal Ibogaine Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Universal Ibogaine's Pretax Margin for the fiscal year that ended in Jul. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Jul. 2024 )/Revenue (A: Jul. 2024 )
=-2.052/2.331
=-88.03 %

Universal Ibogaine's Pretax Margin for the quarter that ended in Apr. 2025 is calculated as

Pretax Margin=Pre-Tax Income (Q: Apr. 2025 )/Revenue (Q: Apr. 2025 )
=-0.066/0.701
=-9.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of -9.42% mean?
Universal Ibogaine (TSXV:IBO) has a Pretax Margin % of -9.42% as of Apr. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Universal Ibogaine and its competitors.
Is Universal Ibogaine's Pretax Margin % too high?
Universal Ibogaine's current Pretax Margin % is -9.42%.
How does Universal Ibogaine's Pretax Margin % compare to LABT and CALC?
Universal Ibogaine's Pretax Margin % of -9.42% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Universal Ibogaine and its competitors. Universal Ibogaine's current Pretax Margin % is -9.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universal Ibogaine stock overvalued right now?
Universal Ibogaine (TSXV:IBO) has a current Pretax Margin % of -9.42%. The current Pretax Margin % is -9.42%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Universal Ibogaine (TSXV:IBO), the current Pretax Margin % is -9.42% as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Universal Ibogaine Business Description

Address C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue South west, Suite 600, Calgary, AB, CAN, T2P 3P2
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.